Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds.

By Kwang-sok Kim, Y. Luu, Charles Chang, D. Fang, Benjamin S. Hsiao, Benjamin Chu, M. Hadjiargyrou. Journal of Controlled Release, 2004

758 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Surfaces, Coatings and Films

View Paper: https://www.semanticscholar.org/paper/ea298bb0896a20f648e2ea47de510ba195c192f6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. Benjamin S. Hsiao
2. Benjamin Chu
3. Vimal Kumar
4. A. Gupta
5. D. Liang
6. Hongyang Ma
7. C. Burger
8. Rong Wang

In Biomedical Engineering

1. Benjamin S. Hsiao
2. Benjamin Chu
3. D. Liang
4. Rong Wang
5. Anthony Gordon Fane
6. Hongyang Ma
7. Y. Liao

Citations in the corpus

• New emerging trends in synthetic biodegradable polymers – Polylactide: A critique (2007, background): “Being a nonflammable polymer, the fibre shows improved self extinguishing characteristics [220–222].”
• Functional electrospun nanofibrous scaffolds for biomedical applications. (2007, background): “hydrophilicity), and (2) to facilitate electrospinning of other more difficult to process biomaterials as a processing aid For example, in first applications, PEG has been incorporated in the electrospun scaffolds in the form of copolymers, such as PEG-g-CHN [43] and PEG-PLA [45,118] described earli”
• Nanofibers and their applications in tissue engineering (2006, neutral): “These include PLA (Tu et al 2003; Yang et al 2004); poly(ethylene terephthalate) (PET) (Ma et al 2005b) for blood vessel tissue engineering; PCL (Li et al 2005c) in neural and cartilage tissue engineering; and several copolymeric compounds such as PLLA-CL as a biomimetic ECM for smooth muscle and en”